4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001178913-23-002227
Options or other derivatives
- Chief Financial Officer acquired 167,860 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fatal Sigal · Chief Financial Officer
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-14 | Grant or award : show line 1 in the form Option to Purchase American Depositary Shares | +102,860 | 167,860 | D |
| 2022-11-08 | Grant or award : show line 2 in the form Option to Purchase American Depositary Shares | +29,400 | 65,000 | D |
| 2021-11-11 | Grant or award : show line 3 in the form Option to Purchase American Depositary Shares | +35,600 | 35,600 | D |
Loading xslF345X04/ownership.xml…